Clinical Trials Logo

Arterial Ulcer clinical trials

View clinical trials related to Arterial Ulcer.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05170984 Recruiting - Diabetic Foot Ulcer Clinical Trials

MAtrix Therapy for Hard-to-heal ChrOnic Wounds

MATHCOW
Start date: February 10, 2022
Phase: N/A
Study type: Interventional

CACIPLIQ20® is currently a class III CE marked medical device available in various European and non-European countries, and currently primarily used in managing hard-to-heal wounds. This study is a prospective and standardized recording of patients' data followed in real-life conditions to appreciate the benefits of a therapeutic strategy including CACIPLIQ20® use. It also aims at collecting data to follow-up the device's efficacy and safety and estimate its cost-effectiveness.